Interferon beta- 1b er blevet givet til voksne cancerpatienter i doser op til 5. 500 mikrogram (176 millioner IE) intravenøst 3 gange om ugen, uden at der opstod alvorlige bivirkninger på vitale funktioner.
Interferon beta-1b has been given without serious adverse events compromising vital functions to adult cancer patients at individual doses as high as 5,500 microgram (176 million IU) intravenously three times a week.